Medicare Enrolled
Dr. Daniel Patterson, MD,PHD, MRCP,
Hematology & Oncology · Ocala, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patterson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patterson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patterson
Dr. Daniel Patterson is a hematology & oncology specialist in Ocala, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patterson performed 106,886 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patterson received a total of $35,086 from 68 pharmaceutical and/or device companies across 789 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patterson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 6% volume in FL
$35,086 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 80575 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗106,886
Medicare services
Top 6% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
70,380 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 7,920 | $18 | $45 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
6,748 | $0 | $0 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
5,660 | $6 | $20 |
| Anti-nausea injection (ondansetron/Zofran) | 4,229 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,102 | $8 | $12 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,034 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,333 | $96 | $177 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
851 | $95 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
766 | $11 | $39 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
639 | $12 | $35 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
563 | $10 | $75 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
508 | $22 | $70 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
488 | $1 | $5 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
394 | $1 | $4 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
278 | $64 | $153 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
269 | $24 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
248 | $70 | $103 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
245 | $1 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
230 | $98 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
222 | $139 | $350 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
215 | $48 | $125 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
137 | $22 | $100 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
127 | $10 | $50 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
115 | $15 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $129 | $265 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
58 | $4 | $17 |
| Stool test for blood A laboratory test that checks a stool sample for hidden blood using a chemical reaction. This test helps detect bleeding in the digestive tract. |
27 | $4 | $16 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
21 | $138 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
67.3% high complexity
25.3% medium
7.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,086
Total received (2018-2024)
Avg $5,012/year across 7 years
Top 18% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
789
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,521
2023
$2,547
2022
$3,202
2021
$3,094
2020
$1,298
2019
$17,579
2018
$2,845
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,187
AstraZeneca Pharmaceuticals LP
$679
PFIZER INC.
$378
Eisai Inc.
$278
Celgene Corporation
$268
Lilly USA, LLC
$173
Astellas Pharma US Inc
$165
Amgen Inc.
$153
JAZZ PHARMACEUTICALS INC.
$105
ABBVIE INC.
$100
Daiichi Sankyo Inc.
$100
Regeneron Healthcare Solutions, Inc.
$88
GENZYME CORPORATION
$72
SERVIER PHARMACEUTICALS LLC
$62
Karyopharm Therapeutics Inc.
$62
RECORDATI_RARE_DISEASES_INC.
$61
Genentech USA, Inc.
$60
Alexion Pharmaceuticals, Inc.
$50
Novocure Inc.
$50
Incyte Corporation
$50
GlaxoSmithKline, LLC.
$50
Tempus AI, Inc
$46
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
E.R. Squibb & Sons, L.L.C.
$41
Bayer Healthcare Pharmaceuticals Inc.
$38
EMD Serono, Inc.
$36
PUMA BIOTECHNOLOGY, INC.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Merck Sharp & Dohme LLC
$21
Aveo Pharmaceuticals, Inc.
$21
SHIELD THERAPEUTICS INC
$20
Pharmacosmos Therapeutics Inc.
$18
Top 3 companies account for 49.6% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$11,421
E.R. Squibb & Sons, L.L.C.
$5,094
Novartis Pharmaceuticals Corporation
$3,229
AstraZeneca Pharmaceuticals LP
$2,516
Lilly USA, LLC
$972
PFIZER INC.
$819
Amgen Inc.
$819
Astellas Pharma US Inc
$742
EMD Serono, Inc.
$664
Incyte Corporation
$648
Janssen Biotech, Inc.
$571
Foundation Medicine, Inc.
$568
Eisai Inc.
$523
Regeneron Healthcare Solutions, Inc.
$449
Seattle Genetics, Inc.
$429
Seagen Inc.
$427
JAZZ PHARMACEUTICALS INC.
$368
Merck Sharp & Dohme Corporation
$294
GENZYME CORPORATION
$287
Takeda Pharmaceuticals U.S.A., Inc.
$246
Daiichi Sankyo Inc.
$240
GlaxoSmithKline, LLC.
$235
Pharmacyclics LLC, An AbbVie Company
$217
Genentech USA, Inc.
$201
Sobi, Inc
$183
ASD SPECIALTY HEALTHCARE, LLC
$172
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Rigel Pharmaceuticals, Inc.
$162
Karyopharm Therapeutics Inc.
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$148
EISAI INC.
$145
TOLMAR Pharmaceuticals, Inc.
$140
Dendreon Pharmaceuticals LLC
$135
Bayer HealthCare Pharmaceuticals Inc.
$119
PAINTEQ LLC
$104
Merck Sharp & Dohme LLC
$104
Teva Pharmaceuticals USA, Inc.
$102
SERVIER PHARMACEUTICALS LLC
$102
ABBVIE INC.
$100
Clovis Oncology, Inc.
$80
Octapharma USA, Inc.
$65
RECORDATI_RARE_DISEASES_INC.
$61
Ipsen Biopharmaceuticals, Inc
$60
PharmaEssentia USA Corporation
$59
Alexion Pharmaceuticals, Inc.
$50
Janssen Pharmaceuticals, Inc
$50
Novocure Inc.
$50
Tempus AI, Inc
$46
AVEO Pharmaceuticals, Inc.
$46
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
TAIHO ONCOLOGY, INC.
$39
Bayer Healthcare Pharmaceuticals Inc.
$38
Agios Pharmaceuticals, Inc.
$38
Tolmar, Inc.
$36
Taiho Oncology, Inc.
$28
G1 Therapeutics, Inc.
$28
CSL Behring
$26
Abbott Laboratories
$26
Exelixis Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$25
Sun Pharmaceutical Industries Inc.
$23
Aveo Pharmaceuticals, Inc.
$21
SHIELD THERAPEUTICS INC
$20
Partner Therapeutics, Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
EUSA Pharma (US) LLC
$17
MorphoSys, US Inc.
$16
Gilead Sciences, Inc.
$12
Top 3 companies account for 56.3% of all-time payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · ALIMTA · Alecensa · Aliqopa · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · Bavencio · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELIGARD · ELIQUIS · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Leukine · Luspatercept · MEKINIST · MONJUVI · MVASI · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Odomzo · Optune · PADCEV · PAINTEQ · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Polivy · Pomalyst · Proclaim IPG · Prolia · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rubraca · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · ULTOMIRIS · VELCADE · VENCLEXTA · VERZENIO · Vectibix · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
6
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
MARION COMMUNTIY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patterson is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patterson experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Patterson performed 70,380 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patterson receive payments from pharmaceutical companies?
Yes. Dr. Patterson received a total of $35,086 from 68 companies across 789 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patterson's costs compare to other hematology & oncology specialists in Ocala?
Dr. Patterson's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patterson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Ocala
Browse hematology & oncology specialists in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology